Skip to content
DataLookout
Menu

NCT07912034

EHR Integrated Remote Patient Monitoring to Reduce Readmission for Patients With Bladder Cancer Undergoing Cystectomy

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Recruitment opened
    • Start date changed from estimate of Dec 1, 2026 to Nov 5, 2026
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Trial randomization meeting goal of 50 patients (feasibility)
Timeframe: Up to 6 months

Secondary (3)

Intervention deployment in > 90% of patients randomized to intervention arm (feasibility)
Trial enrollment of ≥ 50% of eligible patients (acceptability)
Hospital free days

Arms and interventions

Arm I (EHR integrated remote monitoring app)Experimental

Patients receive access to the MyUofMHealth App and, starting at discharge, receive notifications, up to 3 times per day with frequency decreasing to daily, then less frequently over time, prompting them to complete medication and pain assessments, record food and fluid intake and exercise and triage/symptom tracking, and provide a direct line of communication to their care team if concerning symptoms arise, up to day 35 post discharge.

Arm II (Standard care)Experimental

Patients receive access to the MyUofMHealth App and undergo standard post-operative care.

Other: Best Practice, Communication Intervention, Interview, Supportive Care, Survey Administration

Behavioral: Smartphone Application-based Intervention

Sites

1 site in 1 country

  • University of Michigan Rogel Cancer CenterAnn Arbor, Michigan, United States